CARsgen’s First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
SHANGHAI, Feb. 10, 2025 /PRNew…
SHANGHAI, Feb. 10, 2025 /PRNew…
SINGAPORE, Feb. 10, 2025 /PRNe…
TOKYO, Feb. 10, 2025 /PRNewswi…
KOROR, Palau, Feb. 9, 2025 /PR…
ISLAMABAD, Pakistan , Feb. 9, …
KOROR, Palau, Feb. 9, 2025 /PR…
SHENZHEN, China, Feb. 8, 2025 …
SHANGHAI, Feb. 8, 2025 /PRNews…
SHANGHAI, Feb. 8, 2025 /PRNews…
SHANGHAI, Feb. 7, 2025 /PRNews…